Infections AIDS HIV

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
AIDS/HIV Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage AIDS/HIV Projects
--Aurobindo Pharma Ltd.
--Advanced Viral Research Corp
--Cellegy Pharmaceuticals Inc
--Bionor Immuno AS
--FIT Biotech Oyj Plc.
--Cipla Ltd.
--Gilead Sciences Inc
--GenVec Inc
--Hemispherx Biopharma Inc
--Heidelberg Pharma AG
--Johnson & Johnson
--Japan Tobacco Inc.
--Pfizer Inc
--Medivir AB
--Pharmexa A/S
--Pharmasset, Inc.
--Samaritan Pharmaceuticals Inc
--Ranbaxy Laboratories Ltd.
--Tibotec BVBA
--Sanofi-Aventis

--Top Companies in early stage AIDS/HIV Projects
--Biotherapix SLU
--Bavarian Nordic AS
--Genzyme Corporation
--Cellegy Pharmaceuticals Inc
--ImQuest Pharmaceuticals, Inc.
--GlaxoSmithKline plc
--Medivir AB
--KUREHA CORPORATION
--erly Kureha Chemical Industry Co., Ltd.)
--Myriad Genetics Inc
--Merck & Co Inc
--Oxford BioMedica plc
--Octamer, Inc.
--Pharmexa A/S
--Panacos Pharmaceuticals Inc
--Roche Holdings Ltd
--Presidio Pharmaceuticals, Inc.
--Tobira Therapeutics, Inc.
--Samaritan Pharmaceuticals Inc
--VGX Pharmaceuticals, Inc
--United Biomedical, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View